Existing investor Boehringer Ingelheim Venture Fund co-led the cell therapy developer's series A round, which also featured MBL Venture Capital.

Darpa is among the investors in Synchron, which is looking to trial minimally-invasive neural interface technology based on research conducted at Melbourne University.

Viracta Therapeutics will license its lead drug candidate to NantKwest, which is leading a series B round Viracta has said could reach $18.4m.

The home healthcare specialist has taken its overall funding to $35m with a Mahindra and Mahindra-led series B round that will support expansion.

Northwestern Mutual has invested in Amino, a healthcare company focused on helping patients estimate bills and book appointments with local physicians.

The Johnson & Johnson-backed portable respirator developer has secured $12.7m according to a regulatory filing, taking its overall funding to $62m.

Eli Lilly is the oncology antibody developer's largest shareholder, while other investors include Celgene and EMS subsidiary Brace Pharma Capital.

The online healthcare marketplace, which is backed by Telstra and Seven West Media, has attracted more than $20m to support expansion plans.

Sucampo has acquired the Lundbeck and Pfizer-backed rare diseases treatment developer for $200m in stock and cash, less than a year after it closed a $42m series A round.

IDG Capital-backed Xiaolu Yiguan, which offers traditional Chinese medicine and health consultancy, has raised 14.5m in a round co-led by Redpoint Ventures and Sinovation Ventures.